Multilevel stressors and systemic and tumor immunity in Black and White women with breast cancer

JAMA Network Open

2025-02-14

(Press-News.org) About The Study: The findings of this cross-sectional study of Black and white women with breast cancer suggest that perceived stress, perceived inadequate social support, perceived racial and ethnic discrimination, and neighborhood deprivation were associated with deleterious alterations to the systemic and tumor immune environment, particularly for Black women. Understanding biology as a possible mediator of cancer health disparities may inform prevention and public health interventions.

Corresponding Author: To contact the corresponding author, Stefan Ambs, PhD, MPH, email ambss@mail.nih.gov.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2024.59754)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.59754?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=021425

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

Childhood lifestyle behaviors and mental health symptoms in adolescence

2025-02-14

About The Study: This cohort study of Finnish children and adolescents found that higher physical activity and lower screen time from childhood were associated with perceived stress and depressive symptoms in adolescence. These findings emphasize reducing screen time and increasing physical activity to promote mental health in youth. Corresponding Author: To contact the corresponding author, Eero A. Haapala, PhD, email eero.a.haapala@jyu.fi. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.60012) Editor’s Note: Please see the ...

Most comprehensive study on U.S. health care spending by county reveals wide variation

2025-02-14

At $144 billion, type 2 diabetes was the most expensive single health condition. Emergency department care had the fastest growth. SEATTLE, Wash., Feb. 14, 2025 – Researchers present the most comprehensive study on U.S. health care spending and variations across 3,110 counties by four payers, 148 health conditions, 38 age/sex groups, and seven types of care. That’s according to the newest and most extensive studies published in JAMA and JAMA Health Forum today. As part of this study, researchers ...

Tracking U.S. health care spending by health condition and county

2025-02-14

About The Study: Broad variation in health care spending was observed across U.S. counties. Understanding this variation by health condition, sex, age, type of care, and payer is valuable for identifying outliers, highlighting inequalities, and assessing health care gaps. Corresponding Author: To contact the corresponding author, Joseph L. Dieleman, PhD, email dieleman@uw.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2024.26790) Editor’s ...

Drivers of variation in health care spending across U.S. counties

2025-02-14

About The Study: In this cross-sectional study, variation in health care spending among U.S. counties was largely related to variation in service utilization. Understanding the drivers of spending variation in the U.S. may help policymakers assess the allocation of health care resources. Corresponding Author: To contact the corresponding author, Joseph L. Dieleman, PhD, email dieleman@uw.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamahealthforum.2024.5220) Editor’s ...

INSEAD webinar on scaling affordable healthcare: balancing purpose, innovation & growth

2025-02-14

Digital@INSEAD is hosting a free INTHECASE webinar, “Scaling Affordable Healthcare: Balancing Purpose, Innovation & Growth” on Thursday, 20 February 2025 at 9.00 am ET / 3.00 pm CET (60 min). Register and join the webinar for an engaging discussion on Access Afya’s journey to scale its affordable healthcare model while staying true to its mission of serving underserved communities. Explore how the company: Balances mission and growth Navigates the complexities of scaling up Leverages technology and data to improve care delivery With a proven business model in Kenya, ...

A new switch for the cell therapies of the future

2025-02-14

The body regulates its metabolism precisely and continuously, with specialised cells in the pancreas constantly monitoring the amount of sugar in the blood, for example. When this blood sugar level increases after a meal, the body sets a signal cascade in motion in order to bring it back down. In people suffering from diabetes, this regulatory mechanism no longer works exactly as it should. Those affected therefore have too much sugar in their blood and need to measure their blood sugar level and inject themselves with insulin in order to regulate it. This is ...

Utilizing a nanomedicine to achieve tumor catalysis-enhanced differentiation therapy

2025-02-14

Tumor metastasis, recurrence, and therapeutic resistance are the main reasons for the failure of clinical cancer treatment. Studies have found that the presence of cancer stem-like cells (CSCs) with stemness characteristics in malignant tumors is a key factor leading to the above undesirable results. However, there are significant limitations to current strategies with traditional molecular drugs for combating CSCs, such as the unsatisfactory in vivo stemness-suppressing efficiency, and the lack of powerful tumor-specific lethal action, resulting in remaining massive bulk tumor cells that can convert to CSCs via epithelial-to-mesenchymal ...

Report documents the devastation of the ancient city of Palmyra, a World Heritage Site, after the fall of the Assad regime

2025-02-14

Palmyra is one of the most famous sites in Syria for its extraordinary heritage and archaeological remains. Inscribed on the World Heritage List in 1980, the city saw much of its heritage destroyed during the war. Following the liberation of Syria from the Assad regime on 8 December, a multidisciplinary team has carried out a field study in Palmyra to assess the current state of the archaeological monuments and the surrounding residential areas, comparing them with their condition before the start of the Syrian uprising in 2011. The report is an initiative of Palmyrene Voices of the NGO Heritage for Peace in collaboration with the CSIC's Milà i Fontanals Institution. ‘We ...

Major trial to determine if ketamine can stop deadly epilepsy seizures

2025-02-14

University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to determine if the powerful anesthetic ketamine can save patients from prolonged, life-threatening grand mal seizures that won’t respond to other treatments. “Status epilepticus,” as the seizures are known, are seizures that last more than five minutes or that strike repeatedly without the ...

INSEAD Webinar to explore the future of agentic AI & autonomous organizations

2025-02-14

Digital@INSEAD is hosting a free TECH TALK X webinar, “The Future of Agentic AI & Autonomous Organizations” on Thursday, 27 February 2025 at 9.00 am ET / 3.00 pm CET (60 min). AI is evolving beyond tools and assistants – it is becoming autonomous. But what is holding enterprises back from fully leveraging Agentic AI? Join in the free webinar for a deep dive with Rotem Alaluf, CEO of Wand – a pioneering platform for enterprise-grade AI systems – and Peter Zemsky, ...

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

Multilevel stressors and systemic and tumor immunity in Black and White women with breast cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: